Pauwelyn Maarten, Ingelaere Sebastian, Hoffmann Ruben, Vijgen Johan, Mairesse Georges H, Blankoff Ivan, Vandekerckhove Yves, de Waroux Jean-Benoit le Polain, Vandenberk Bert, Willems Rik
University Hospitals Leuven, Cardiology, Leuven, Belgium.
KU Leuven, Department of Cardiovascular Sciences, Leuven, Belgium.
J Geriatr Cardiol. 2023 Jan 28;20(1):23-31. doi: 10.26599/1671-5411.2023.01.007.
Implantable cardiac defibrillators (ICD) implantation in the very elderly remains controversial. We aimed to describe the experience and outcome of patients over 80 years old implanted with an ICD in Belgium.
Data were extracted from the national QERMID-ICD registry. All implantations performed in octogenarians between February 2010 and March 2019 were analysed. Data on baseline patient characteristics, type of prevention, device configuration and all-cause mortality were available. To determine predictors of mortality, multivariable Cox proportional hazard regression modelling was performed.
Nationwide, 704 primo ICD implantations were performed in octogenarians (median age 82, IQR 81-83 years; 83% male and 45% secondary prevention). During a mean follow-up of 3.1 ± 2.3 years, 249 (35%) patients died, of which 76 (11%) within the first year after implantation. In multivariable Cox regression analysis age (HR = 1.15, = 0.004), oncological history (HR = 2.43, = 0.027) and secondary prevention (HR = 2.23, = 0.001) were independently associated with 1-year mortality. A better preserved left ventricular ejection fraction (LVEF) was associated with a better outcome (HR = 0.97, = 0.002). Regarding overall mortality multivariable analysis withheld age, history of atrial fibrillation, centre volume and oncological history as significant predictors. Higher LVEF was again protective (HR = 0.99, = 0.008).
Primary ICD implantation in octogenarians is not often performed in Belgium. Among this population, 11% died within the first year after ICD implantation. Advanced age, oncological history, secondary prevention and a lower LVEF were associated with an increased one-year mortality. Age, low LVEF, atrial fibrillation, centre volume and oncological history were indicative of higher overall mortality.
在高龄老年人中植入植入式心脏除颤器(ICD)仍存在争议。我们旨在描述比利时80岁以上植入ICD患者的经验和结局。
数据取自国家QERMID-ICD登记处。对2010年2月至2019年3月期间在八旬老人中进行的所有植入手术进行分析。有关于患者基线特征、预防类型、设备配置和全因死亡率的数据。为了确定死亡率的预测因素,进行了多变量Cox比例风险回归建模。
在全国范围内,八旬老人中进行了704例首次ICD植入(中位年龄82岁,四分位间距81 - 83岁;83%为男性,45%为二级预防)。在平均3.1±2.3年的随访期间,249例(35%)患者死亡,其中76例(11%)在植入后的第一年内死亡。在多变量Cox回归分析中,年龄(HR = 1.15,P = 0.004)、肿瘤病史(HR = 2.43,P = 0.027)和二级预防(HR = 2.23,P = 0.001)与1年死亡率独立相关。较好保留的左心室射血分数(LVEF)与较好的结局相关(HR = 0.97,P = 0.002)。关于总体死亡率,多变量分析将年龄、房颤病史、中心手术量和肿瘤病史作为显著预测因素。较高的LVEF再次具有保护作用(HR = 0.99,P = 0.008)。
在比利时,八旬老人中很少进行首次ICD植入。在这一人群中,11%在ICD植入后的第一年内死亡。高龄、肿瘤病史、二级预防和较低的LVEF与1年死亡率增加相关。年龄、低LVEF、房颤、中心手术量和肿瘤病史表明总体死亡率较高。